Cargando…
Modifying glycyrrhetinic acid liposomes with liver-targeting ligand of galactosylated derivative: preparation and evaluations
In this study, novel glycyrrhetinic acid (GA) liposomes modified with a liver-targeting galactosylated derivative ligand (Gal) were prepared using a film-dispersion method. To characterize the samples, particle size, zeta potential, drug loading, and encapsulation efficiency were performed. Moreover...
Autores principales: | Chen, Jing, Chen, Yuchao, Cheng, Yi, Gao, Youheng, Zheng, Pinjing, Li, Chuangnan, Tong, Yidan, Li, Zhao, Luo, Wenhui, Chen, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731934/ https://www.ncbi.nlm.nih.gov/pubmed/29254224 http://dx.doi.org/10.18632/oncotarget.22143 |
Ejemplares similares
-
Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery
por: Chen, Jing, et al.
Publicado: (2017) -
Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate
por: Zhu, Jing, et al.
Publicado: (2018) -
Preparation and in vitro and in vivo evaluations of 10-hydroxycamptothecin liposomes modified with stearyl glycyrrhetinate
por: Zhou, Ting, et al.
Publicado: (2019) -
A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation
por: Chen, Jingde, et al.
Publicado: (2015) -
Preparation of docetaxel-loaded, glycyrrhetinic acid-modified nanoparticles and their liver-targeting and antitumor activity
por: Xue, Hantao, et al.
Publicado: (2021)